While the monsoon rains breathe life into the earth, they also bring along seasonal infections like Dengue, Hepatitis A, and Typhoid amongst others. It is during this time that protecting oneself against these viruses becomes pivotal. A balanced diet, with an adequate amount of green vegetables and fruits, can prove to be your best defence against pathogens and infections. By incorporating nutrient-dense vegetables into your diet, you can strengthen your immune system, support digestion, and reduce the risk of monsoon-related health issues, ensuring you stay healthy and resilient during the season.
Nature offers us an array of vegetables that are not just seasonal favorites but also powerful allies in maintaining our well-being. Bitter gourd, with its distinctive taste, stands out for its remarkable detoxifying properties. Often overlooked due to its bitterness, this vegetable works wonders in cleansing the liver and purifying the blood, which is especially important during the monsoon when infections are more common. Including bitter gourd in your diet can give your immune system the boost it needs to keep you feeling vibrant and protected.
Bottle gourd is another monsoon staple that deserves a place on your plate. Light on the stomach and incredibly easy to digest, this vegetable is a gentle companion for your digestive system, which can be more sensitive during the rainy season. Its high water content also helps keep your body hydrated, ensuring that you feel refreshed and energized even on the dampest of days.
Spinach, with its rich iron content, is a powerful support for your immune system and a natural remedy against anaemia. The antioxidants in spinach not only bolster your immunity but also protect your skin from the infections and damage caused by the humid monsoon climate. As you incorporate spinach into your meals, you’re also nurturing your body’s resilience from the inside out.
Carrots, often associated with good vision, offer much more than just that. Their abundance of beta-carotene, vitamin A, and antioxidants make them a true superfood during the monsoon. Carrots help enhance your immunity, improve your skin health, and protect against infections that thrive in the moist, rainy weather. With every crunchy bite, you’re not only enjoying a tasty treat but also fortifying your body’s defences.
Lastly, there’s okra, or bhindi, a versatile vegetable rich in vitamins A and C, folate, and fibre. The fiber in okra is key to promoting healthy digestion and preventing constipation that can occur during this season. Meanwhile, its vitamins and antioxidants work in tandem to enhance your immune function, providing an extra layer of protection against the seasonal ailments that can dampen your spirits.
(Credit-Canva)
A recent scientific study found an exciting new way to check if someone is likely to get Alzheimer's disease due to their genetics. Instead of current medical tests, which are often costly, complex, and invasive, this new method uses simple eye-tracking technology. This means diagnosing the risk could become much easier for patients and more affordable for healthcare systems.
As you may know, there is currently no cure for Alzheimer's disease. This is a neurodegenerative disease that can affect a person’s memory, skills, as well as behavior. The best way to deal with this disease is by diagnosing it early, so that doctors can provide medicine and treatment options to delay the onset and manage the symptoms. However, it is not easy to spot the symptoms, so how can one know for certain whether they have Alzheimer's disease or not?
This research, which involved scientists from the University of Strathclyde, looked closely at how well this new technique works. The technology is a specific system called ViewMind Atlas. It works by monitoring a person's tiny, subtle eye movements. Then, Artificial Intelligence (AI) software analyzes these movements.
Since the eyes are closely linked to the brain, the way they move can tell doctors about the brain's health and function. The most important part is that this system can successfully identify the genetic risk in people years before they start showing any actual memory loss or other Alzheimer’s symptoms.
To test the system, the researchers studied a group of people from extended families in Colombia who have a known genetic mutation that causes Alzheimer’s. The results were incredibly promising:
For the family members who were already showing symptoms of the disease, the ViewMind Atlas test was 100% accurate in identifying them.
More remarkably, for those who carried the gene but didn't have any symptoms yet (asymptomatic), the test was 96% accurate at correctly identifying their risk. The AI model essentially learned to look at the patterns of eye movement and use them to tell apart the people who had or were likely to get Alzheimer's from those who weren't.
The research team found this eye-tracking test detects the disease earlier than standard cognitive tests, which often fail to flag a problem until it is well underway. The lead scientist, Professor Mario Parra Rodriguez, explained why this is such a big deal. He pointed out that today's common tests are "expensive and invasive," often requiring hospital procedures.
The ViewMind Atlas system, however, helps doctors predict Alzheimer’s risk years in advance. This is key for doctors, who often struggle to figure out if a patient’s mild forgetfulness is just a normal part of getting older or a serious risk of dementia. This new tool could help them act quickly to treat or manage the risk instead of having to wait for the disease to fully develop.
(Credit-Canva)
A new study suggests that GLP-1 drugs like Ozempic and Wegovy, used mainly for weight loss and diabetes, might also lessen the effects of alcohol. While this could be disappointing for social drinkers, experts at Virginia Tech see it as a hopeful new way to help people who struggle with serious alcohol problems.
Alcohol addiction is one of the world’s biggest problems. According to the World Health Organization (WHO) in 2019 alone, approximately 2.6 million deaths worldwide were linked to drinking. While 1.6 million deaths were due to non-communicable diseases, the other 700,000 deaths were caused by injuries.
A massive number of people struggle with alcohol problems. An estimated 400 million people globally, about 7% of the world's population aged 15 and older, were living with alcohol use disorders (AUDs). A large portion of this group, 209 million people, or 3.7% of the adult population, had the more severe condition of alcohol dependence (or addiction).
The WHO explains that we have effective ways to control and reduce the harm caused by alcohol, and countries need to use these strategies more often. At the same time, it’s crucial for every person to know the dangers of drinking and take personal steps to protect themselves from their harmful effects. Could these weight loss drugs become one such viable ways to help bring alcohol addiction down?
GLP-1 medicines work by copying a natural body hormone that manages your appetite and how you digest food. This makes people feel full longer and helps them eat less. For this small study, researchers tested 20 people who were overweight.
Half of them were already taking a regular dose of a GLP-1 drug. On the test day, everyone had an alcoholic drink after a snack. The researchers then watched them for an hour, checking their health and asking how they felt.
The key result was that the group on GLP-1 drugs felt less drunk, even though everyone had the same amount. Crucially, their blood alcohol level rose more slowly. Scientists think that because the drug slows down the body's processes, it slows down how fast the alcohol reaches the brain, which dulls the effects, or the "buzz."
This is important because slow-acting drugs are less likely to be abused. These promising results mean researchers want to run much bigger studies to confirm that GLP-1s can be a real treatment to help people drink less.
The ability of GLP-1 drugs to help with cravings doesn't stop at alcohol. People taking drugs like Ozempic have also reported having fewer cravings for nicotine, opioid drugs, and even less desire for impulse shopping. Other research has already shown this potential: Opioid users on GLP-1s had a 40% lower rate of overdoses in one study.
In a separate trial done by researchers from Loyola University Chicago, these medications were better than standard drugs for alcoholism at keeping patients out of the hospital for alcohol problems. Scientists believe this happens because GLP-1 drugs affect the brain's reward system (called the mesolimbic system), which controls addiction. They change the levels of a chemical called dopamine, which is central to how we feel pleasure and form habits.
Credits: Canva
When most people think of COVID today, they imagine a mild illness, like a cold, a few days of fever, a sore throat, or a cough, before recovery. But for many, the story does not end there. Long COVID, which the World Health Organization defines as symptoms lasting at least three months after infection, has become a lasting reality of the pandemic.
Most studies have focused on describing symptoms such as fatigue, brain fog, and shortness of breath. However, a recent study has shown that long COVID, especially in women, can trigger a chronic condition known as Postural Orthostatic Tachycardia Syndrome (POTS).
Long COVID affects roughly 6% of people who had COVID, with over 200 symptoms recorded. For some, it lasts just a few months, while for “long haulers,” it can continue for years. Measuring the scale of the problem is difficult because symptoms differ widely from person to person. This has sparked debates over what long COVID truly is, what causes it, and even whether it is real.
However, as per Johns Hopkins Medicine, common symptoms include fatigue, brain fog, shortness of breath, headaches, and changes in smell or taste, and multiple organ systems can be affected.
A study from Sweden found that young women with symptomatic long COVID were at a higher risk of developing POTS, adding an extra burden, according to research from the University of Nebraska Medical Center. Among a cohort of predominantly younger women with highly symptomatic post-COVID-19 sequelae (PCS), also called long COVID, there was a notable incidence of POTS. The research noted significantly lower physical activity and capacity in long COVID patients with POTS compared to those without it.
The study examined 467 non-hospitalized, highly symptomatic long COVID patients, 91% of whom were healthy, physically active women before their COVID infection. About 12 months after their initial COVID illness, patients underwent cardiologist evaluations including a 48-hour electrocardiogram, head-up tilt test, and Active Stand Test for those suspected of having POTS.
POTS is a disorder of the autonomic nervous system in which the heart rate rises excessively when standing. This can lead to symptoms like lightheadedness, fatigue, and fainting. In POTS, blood vessels don’t constrict as they should, causing blood to pool in the lower body and reducing blood flow to the brain. The nervous system compensates by releasing hormones that sharply increase heart rate, producing various symptoms, according to Johns Hopkins Medicine.
POTS can be triggered by various factors, including viral or bacterial infections. Researchers believe the coronavirus that causes COVID-19 may act as a trigger, as more people recovering from COVID are showing POTS-like symptoms such as brain fog, rapid heartbeat (tachycardia), and severe chronic fatigue. The overlap in symptoms has prompted doctors to start testing patients for POTS.
Johns Hopkins explains that the autonomic nervous system controls functions we don’t consciously think about, like heart rate, blood pressure, sweating, and body temperature. Problems in these areas can cause symptoms that overlap with other conditions. Patients may have their POTS symptoms dismissed as lingering COVID effects or even psychological issues. Accurate diagnosis is critical, as POTS can be debilitating and requires targeted treatment.
The main goal of initial POTS treatment is to improve blood flow back to the heart, a strategy known as volume expansion therapy. This can include medication-based and non-medication approaches. Physical therapy also plays a key role in increasing blood volume over time. However, it often takes months before patients are able to respond enough to participate fully in physical therapy.
If you are experiencing COVID-like POTS symptoms, consult your healthcare professional for evaluation and guidance.
© 2024 Bennett, Coleman & Company Limited